Subsequent events (Details) - USD ($)	Apr. 15, 2017	Mar. 22, 2017	Mar. 17, 2017	Mar. 01, 2017	Dec. 31, 2016
Subsequent events Details
Company raised from exercise of warrants into common stock amounted		$ 1,765,733
Company holds shares in GVS					$ 500,000
GVS shares valued at					$ 50,000
Company invested in GW Pharmaceuticals PLC Common Stock				$ 1,049,086
Company loaned G Farma an aggregate principal amount Under two secured promissory notes			$ 500,000
Two promissory notes bearing interest each per annum			7.42%
The first promissory note amount is for the purchase of real estate	$ 120,000
Monthly payment for real estate property	1,107
Balloon payment of approximately at maturity for real estate	93,585
The second promissory note is a working capital loan secured by all assets of G Farma	380,000
Monthly payment for working capital loan	3,505
Balloon payment of approximately at maturity for capital loan	296,352
G Farma stock then outstanding equal to number of shares			1.50%
Company received in warrant redemption fees from designees for warrants		$ 56,490
Company will receive a monthly consulting fee in arears per month	$ 1,400
G Farma purchased restricted shares of the Company's Common Stock in a private placement	222,223
Purchase price of a restricted shares per share value	$ 2.25
An aggregate purchase price restricted shares paid	$ 500,002